IDYA - IDEAYA Biosciences, Inc.

📈 Is growth accelerating? 7 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Revenue Growth YoY (%)	-95.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1288%)	—	—	55.4% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+592%)	—	—	—	78.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+881%)	—	—	N/M	-2.5% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-131%)	-72.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1012%)	-39.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-593%)	-30.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-483%)	35.8% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+347%)	230.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2786%)	-33.2% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-515%)	56.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+609%)	-72.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1000%)	0.1% Caution Caution Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-99%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	-38.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-35.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	39.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-29.4% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-54.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-198.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-30.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-36.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-8.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	3.7% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	N/M	12.3% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	-10.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	-72.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	-45.1% Weak ↓ Weak Declining Year-over-year change in net income	-36.5% Weak ↓ Weak Declining Year-over-year change in net income	36.1% Excellent ↑ Excellent Improving Year-over-year change in net income	N/M	-46.8% Weak ↑ Weak Improving Year-over-year change in net income	-82.4% Weak ↑ Weak Improving Year-over-year change in net income	-283.8% Weak ↓ Weak Declining Year-over-year change in net income	-88.9% Weak ↓ Weak Declining Year-over-year change in net income	-89.0% Weak ↓ Weak Declining Year-over-year change in net income	-67.4% Weak ↓ Weak Declining Year-over-year change in net income	-40.3% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-26.6% Weak ↑ Weak Improving Year-over-year change in net income	-68.7% Weak → Weak Stable Year-over-year change in net income	-32.9% Weak ↑ Weak Improving Year-over-year change in net income	N/M	-101.5% Weak ↑ Weak Improving Year-over-year change in net income	-55.3% Weak ↑ Weak Improving Year-over-year change in net income	-254.7% Weak ↓ Weak Declining Year-over-year change in net income	-135.1% Weak ↓ Weak Declining Year-over-year change in net income	11.7% Fair ↓ Fair Declining Year-over-year change in net income	25.1% Excellent ↓ Excellent Declining Year-over-year change in net income	52.4% Excellent ↑ Excellent Improving Year-over-year change in net income	55.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-16.3% Weak ↓ Weak Declining Year-over-year change in net income	-25.9% Weak ↓ Weak Declining Year-over-year change in net income	-25.9% Weak ↓ Weak Declining Year-over-year change in net income	16.0% Good Good Year-over-year change in net income	-52.3% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	N/M	-35.6% Weak Weak Year-over-year change in free cash flow	-23.0% Weak Weak Year-over-year change in free cash flow	—	N/M	-64.3% Weak ↓ Weak Declining Year-over-year change in free cash flow	-16.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	—	-12.4% Weak ↓ Weak Declining Year-over-year change in free cash flow	28.9% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-4.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	—	18.2% Good Good Year-over-year change in free cash flow	-7.6% Weak Weak Year-over-year change in free cash flow	—	—	-83.2% Weak Weak Year-over-year change in free cash flow	-38.0% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	8.4% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	35.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	-5.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	39.3% Excellent Excellent Compound annual revenue growth over 3 years	91.3% Excellent Excellent Compound annual revenue growth over 3 years	—	—	33.2% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	-28.1% Weak Weak Compound annual revenue growth over 3 years	-3.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	2.7% Caution ↑ Caution Improving Compound annual revenue growth over 5 years	0.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-2.0% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	0.6% Weak Weak Compound annual revenue growth over 5 years	87.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	—	—	223.2% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Operating Margin (%) (%)	—	—	—	—	52.2% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+248%)	—	—	—	—	—	—	—	-417.1% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2881%)	—	-333.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2323%)	—	2.2% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-85%)	-384.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2664%)	-125.2% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-935%)	—	-130.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-970%)	-126.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-941%)	-126.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-940%)	-49.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-433%)	-55.7% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-471%)	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	57.4% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+378%)	—	—	—	—	—	—	—	-341.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2945%)	—	-300.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2600%)	—	5.4% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-55%)	-377.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3241%)	-123.4% Weak → Weak Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1128%)	—	-129.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1175%)	-125.0% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1142%)	-124.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1137%)	-48.6% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-505%)	-54.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-558%)	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	68.4% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	-382.9% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	-353.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	—	-85.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-374.9% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-176.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	—	-144.0% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-154.3% Weak → Weak Stable Free cash flow as a percentage of revenue Optimal: > 10%	-203.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-111.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.75x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.96x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.14x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.72x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.18x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-15.65x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.43x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.12x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.63x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.29x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-18.26x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.10x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.79x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	1.01x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.09x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	-10.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	7.8% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	-7.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-6.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.3% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-5.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-6.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	0.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-4.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-2.9% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-3.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-3.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-2.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-5.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-11.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-7.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	13.7% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	14.7% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	26.4% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	21.3% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-11.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.3% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-10.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-7.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-12.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-5.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-7.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-4.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-2.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-12.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Return on Common Equity (%) (%)	-11.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-177%)	-9.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-10.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-8.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	10.9% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-27%)	-8.1% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-154%)	-7.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-12.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	-4.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	-5.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-138%)	-4.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-128%)	-5.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	-5.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-136%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-7.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-6.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-146%)	0.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-97%)	-8.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-4.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-132%)	-6.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-140%)	-3.6% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	-4.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-130%)	-3.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-126%)	-2.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-117%)	-2.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-117%)	-7.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-148%)	-13.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-190%)	-10.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-172%)	-9.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-166%)	-8.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-159%)	16.5% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+10%)	17.5% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+17%)	32.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+114%)	24.9% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+66%)	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	-22297.67x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-6492.70x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4251.42x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1309.91x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3047.82x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2516.08x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2021.46x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1888.79x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	47.14x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	-1406.19x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-888.75x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1148.06x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-650.72x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-613.94x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-480.79x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-264.00x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-249.80x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-599.52x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-594.19x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-514.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-258.29x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-420.58x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-3044.33x Weak Weak Operating income divided by interest expense Optimal: > 5x	-4542.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—
Net Debt (USD)	$-261.45M	$-272.59M	$-157.52M	$-112.83M	$-298.93M	$-114.64M	$-130.00M	$-84.38M	$-400.28M	$-183.05M	$-108.34M	$-157.02M	$-151.85M	$-102.84M	$-67.24M	$-68.63M	$-101.95M	$-49.11M	$-55.29M	$-92.05M	$-108.43M	$-90.43M	$-136.75M	$-72.04M	$-81.24M	$-147.54M	$-35.46M	$-34.07M	$-38.85M	$-88.11M	$-35.30M	$-20.50M	$-21.48M	$-24.87M	—	$-5.96M	—

📊 What does each share earn? 6 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Revenue per Share (USD)	$0.10	$0.10	$0.07	—	$2.35	—	—	—	—	—	$0.00	—	$0.13	$0.06	$0.16	—	$0.74	$0.15	—	—	$0.24	$0.27	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-1.22	$-1.22	$-1.11	$-0.94	$1.35	$-0.88	$-0.82	$-1.55	$-0.60	$-0.68	$-0.53	$-0.52	$-0.46	$-0.50	$-0.49	$-0.54	$0.04	$-0.57	—	$-0.49	$-0.31	$-0.33	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.91	$-0.97	$-0.86	—	$1.61	$-0.71	$-0.70	—	$-0.58	$-0.43	$-0.60	—	$-0.51	$-0.61	$-0.58	—	$-0.63	$-0.57	—	—	$-0.34	$-0.41	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$11.30	$12.44	$10.67	$11.65	$12.34	$10.85	$11.70	$12.24	$13.70	$11.95	$12.51	—	$8.47	$8.92	$6.90	—	$9.15	$6.97	$7.47	—	$8.41	$7.31	$7.22	—	—	—	$4.38	—	—	—	—	—	—	—	—	—	—
Tangible Book Value per Share (USD)	$11.30	$12.44	$10.67	$11.65	$12.34	$10.85	$11.70	$12.24	$13.70	$11.95	$12.51	—	$8.47	$8.92	$6.90	—	$9.15	$6.97	$7.47	—	$8.41	$7.31	$7.22	—	—	—	$4.38	—	—	—	—	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	102.94M	92.06M	88.70M	—	88.53M	88.47M	88.36M	—	86.19M	77.96M	75.11M	—	60.00M	56.25M	48.37M	—	40.30M	38.66M	—	—	37.77M	32.85M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$775.56M	$781.35M	$631.28M	$607.91M	—	—	$657.03M	$643.64M	—	—	$684.39M	—	—	—	$314.14M	—	—	—	$199.09M	—	—	—	$272.03M	—	—	—	$82.12M	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$1.09B	$1.20B	$937.27M	$1.02B	$1.09B	$959.65M	$1.02B	$1.06B	$1.18B	$931.66M	$935.31M	$621.09M	$508.05M	$501.61M	$333.81M	$349.45M	$368.77M	$269.32M	$288.67M	$301.51M	$317.63M	$240.26M	$233.13M	$198.27M	$195.43M	$172.06M	$89.10M	$100.40M	$110.41M	$120.61M	$-58.06M	$-48.95M	$-40.74M	$-28.05M	$-15.74M	$-15.74M	$-4.13M

📋 What is driving earnings? 4 metrics

Metric	Q3 FY2026 Sep 30, 2026 10-Q ↗	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Sales/Revenue/Turnover (USD)	$10.24M	$8.86M	$6.56M	$10.88M	$207.83M	—	—	$7.00M	—	—	$0.00	$3.92M	$8.04M	$3.54M	$7.88M	$4.02M	$29.70M	$5.85M	$11.36M	$2.96M	$8.98M	$8.76M	$7.25M	$10.57M	$8.97M	—	—	—	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$614.00K	$688.00K	$688.00K	$721.00K	$661.00K	$718.00K	$600.00K	$572.00K	$577.00K	$622.00K	$616.00K	$629.00K	$640.00K	$619.00K	$588.00K	$558.00K	$569.00K	$510.00K	$464.00K	$448.00K	$451.00K	$444.00K	$382.00K	$361.00K	$347.00K	$337.00K	$336.00K	$330.00K	$324.00K	$298.00K	$293.00K	$263.00K	$223.00K	—	—	—	—
Net Income, GAAP (USD)	$-125.75M	$-112.45M	$-98.54M	$-83.27M	$119.24M	$-77.49M	$-72.18M	$-130.31M	$-51.82M	$-52.77M	$-39.57M	$-33.95M	$-27.44M	$-27.93M	$-23.64M	$-24.20M	$1.61M	$-22.06M	$-14.01M	$-18.21M	$-11.58M	$-10.95M	$-9.02M	$-5.13M	$-4.93M	$-12.39M	$-12.04M	$-10.78M	$-10.97M	$-10.66M	$-9.57M	$-8.56M	$-13.05M	$-7.00M	—	—	—
Operating Cash Flow (USD)	$-93.48M	$-88.21M	$-75.17M	$-90.50M	$142.21M	$-62.47M	$-60.34M	$-121.66M	$-49.23M	$-32.88M	$-43.81M	$-23.75M	$-30.17M	$-33.46M	$-27.84M	$-23.37M	$-24.17M	$-19.99M	$-19.65M	$-16.66M	$-12.47M	$-12.93M	$-13.72M	$-11.60M	$90.21M	$-13.61M	$-9.54M	$-8.71M	$-10.55M	$-10.27M	$-9.79M	$-7.48M	$-8.69M	—	—	—	—

IDEAYA Biosciences, Inc.

Analytical Summary

37-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IDYA with peers